Molecular and Clinical Characterization of PD-1 in Breast Cancer Using Large-Scale Transcriptome Data

Despite the impressive impact of PD-1 (programmed cell death protein 1)-targeted cancer immunotherapy, a great part of patients with cancer fail to respond. PD-1 impact on immune cells in addition to T cells, and the synergistic role of PD-1 with other immune modulators remain largely unknown. To fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qiang, Cheng, Ran, Kong, Xiangyi, Wang, Zhongzhao, Fang, Yi, Wang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718028/
https://www.ncbi.nlm.nih.gov/pubmed/33329517
http://dx.doi.org/10.3389/fimmu.2020.558757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718028/
https://www.ncbi.nlm.nih.gov/pubmed/33329517
http://dx.doi.org/10.3389/fimmu.2020.558757

Ejemplares similares